Medtronic Raised to Outperform by RBC on Valuation, Fundamentals
RBC Capital Upgrades Medtronic(MDT.US) to Buy Rating, Raises Target Price to $105
RBC Capital Markets Upgrades Medtronic to 'Outperform' on Growth Confidence
MDT Stock Trades Near 52-Week High: Is It a Smart Buy Now?
Medtronic Launches Avalus Ultra Valve in Europe
Blood Glucose Monitoring Devices Focused Market Insights 2024-2029 With Exclusive Data on 40 Vendors Including Key Players - F. Hoffmann-La Roche, Abbott, Dexcom, Medtronic, Ascensia, and LifeScan IP